Golden Developin (DVLP) Stock Price, News & Analysis
Company Description
Golden Developin (OTC Link: DVLP) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $141.3K.
For FY2022, Golden Developin reported net income of -$1.4M and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for DVLP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Golden Developin (DVLP) stock last closed at $0.0000. At a market capitalization of $141.3K, DVLP is classified as a micro-cap stock with approximately 1.4B shares outstanding.
Latest News
Golden Developin has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all DVLP news →
SEC Filings
Financial Highlights
operating income reached -$646K, and net income was -$1.4M. Diluted earnings per share stood at $0.00. The company generated $183K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
DVLP Company Profile & Sector Positioning
Golden Developin (DVLP) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DVLP often look at related companies in the same sector, including Centr Brands (CNTRF), Pineapple Express Cannabis Co (PNXP), Viaderma (VDRM), Xebra Brands (XBRAF), and Cryomass Technologies Inc (CRYM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DVLP's relative position within its industry.